[Policy Recommendations] Requests for the FY2022 Revision of the Medical Service Fee Schedule for the Control of Antimicrobial Resistance (October 12, 2021)
date : 10/13/2021
Tags: AMR
Tokyo, October 12th, 2021 – AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) released requests for the FY2022 Revision of the Medical Service Fee Schedule for the Control of Antimicrobial Resistance. A summary of the requests is as follows.
Over time, bacterium that cause infectious diseases grow immune to the drugs used to treat them. This naturally occurring process is called “antimicrobial resistance” (AMR). This problem can lead to deaths due to infectious diseases that were otherwise preventable. Globally, at least 700,000 people die annually from AMR. If current global trends continue, an estimated 10 million people could die of AMR-related causes every year by 2050. To counter AMR, measures are now advancing around the world. Furthermore, in Japan, approximately 8,000 people already die every year from AMR-related causes, which is more than twice of traffic accidents. Given that Japan’s faces an aging population and globalization, the impact of AMR is likely to grow. To address this issue, we request the current medical service fee schedule be revised to reflect the recommendations described below.
- The revised schedule should facilitate consultations with specialists in infectious disease control.
- The revised schedule should support the placement of infectious disease specialists at university and core hospitals.
- The revised schedule should expand patient eligibility for the premium to support pediatric antimicrobial stewardship measures.
- The revised schedule should facilitate proactive screening for AMR bacteria.
- The revised schedule should enable rapid bacterial culture identification testing.
- The revised schedule should enable rapid antimicrobial susceptibility testing.
- The revised schedule should cover therapeutic drug monitoring during outpatient treatment with voriconazole.
- The revised schedule should facilitate AMR gene detection.
Please see below the PDF file for details.
Top Research & Recommendations Posts
- [Survey Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Preliminary Version) (September 11, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Achieving Equity in Multidisciplinary Pain Treatment and Support Systems for Pain Management (March 31, 2023)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Policy Recommendations] Three Necessary Perspectives for Formulating the Basic Plan for the Promotion of Policies on Dementia: Creating a Society That is Inclusive for All People at All Times (April 1, 2024)
- [New Report] Policy Priorities for Super-Ageing Japan: Health Innovation and Economic Growth in the COVID-19 Pandemic Era (February 24, 2021)
Featured Posts
-
2024-09-26
[Registration Open] HGPI Salon Special Edition “The 2024 U.S. Presidential Election’s Impact on Japan’s Healthcare Policies: Future Implications for U.S.-China Relations and U.S.-Japan Cooperation” (October 28, 2024)
-
2024-10-07
[Registration Open] International Dialogue “Fostering Community and Citizen-led Approaches to AMR: Lessons from Antibiotic Smart Sweden” (October 25, 2024)
-
2024-10-07
[Registration Open] Planetary Health Expert Meeting “Building the Future of Healthcare: A Vision for Sustainable and Resilient Health Systems with GGHH” (November 5, 2024)
-
2024-10-09
[Registration Open] HGPI Salon Special Edition “Overcoming Infectious Diseases through Partnership: Focusing on examples of promoting technology transfer of antimicrobial agents” (October 21, 2024)
-
2024-10-09
[Registration Open] (Webinar) The 128th HGPI Seminar “Viewing Healthcare Disparities Through the Lens of Breast Cancer Treatment” (October 29, 2024)